David Teira
National Distance Education University
I will open the first part of this paper by trying to elucidate the frequentist foundations of RCTs. I will then present a number of methodological objections against the viability of these inferential principles in the conduct of actual clinical trials. In the following section, I will explore the main ethical issues in frequentist trials, namely those related to randomisation and the use of stopping rules. In the final section of the first part, I will analyse why RCTs were accepted for regulatory purposes. I contend that their main virtue, from a regulatory viewpoint, is their impartiality, which is grounded in randomisation and fixed rules for the interpretation of the experiment. Thus the question will be whether Bayesian trials can match or exceed the achievements of frequentist RCTs in all these respects. In the second part of the paper, I will first present a quick glimpse of the introduction of Bayesianism in the field of medical experiments, followed by a summary presentation of the basic tenets of a Bayesian trial. The point here is to show that there is no such thing as “a” Bayesian trial. Bayesianism can ground many different approaches to medical experiments and we should assess their respective virtues separately. Thus I present two actual trials, planned with different goals in mind, and assess their respective epistemic, ethical and regulatory merits. In a tentative conclusion, I contend that, given the constraints imposed by our current regulatory framework, impartiality should preside over the design of clinical trials, even at the expense of many of their inferential and ethical virtues.
Keywords Philosophy of medicine  Philosophy of probability  Clinical trials
Categories (categorize this paper)
Buy the book Find it on
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Translate to english
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 60,842
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

The Case for Frequentism in Clinical Trials (with Discussion).J. Whitehead - 1993 - Statistics in Medicine 12 (15-16):1405-1413.
An Objective Theory of Probability.D. A. Gillies - 1976 - British Journal for the Philosophy of Science 27 (3):292-295.
A Case for Bayesianism in Clinical Trials (with Discussion).Donald A. Berry - 1993 - Statistics in Medicine 12 (15-16):1377-1393.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Uncertainty and the Ethics of Clinical Trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
Statistical Decisions and the Interim Analyses of Clinical Trials.Roger Stanev - 2011 - Theoretical Medicine and Bioethics 32 (1):61-74.
Progress Toward a More Ethical Method for Clinical Trials.Joseph B. Kadane - 1986 - Journal of Medicine and Philosophy 11 (4):385-404.
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
Clinical Equipoise and the Incoherence of Research Ethics.Franklin G. Miller & Howard Brody - 2007 - Journal of Medicine and Philosophy 32 (2):151 – 165.
The Protection of Patients' Rights in Clinical Trials.Marek Czarkowski - 2006 - Science and Engineering Ethics 12 (1):131-138.


Added to PP index

Total views
58 ( #179,099 of 2,438,928 )

Recent downloads (6 months)
1 ( #434,842 of 2,438,928 )

How can I increase my downloads?


My notes